Literature DB >> 25304538

The emperor's new drugs: medication and placebo in the treatment of depression.

Irving Kirsch1.   

Abstract

Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack of serotonin in the brain. Indeed their supposed effectiveness is the primary evidence for the chemical imbalance theory. But analyses of the published data and the unpublished data that were hidden by the drug companies reveal that most (if not all) of the benefits are due to the placebo effect. Some antidepressants increase serotonin levels, some decrease it, and some have no effect at all on serotonin. Nevertheless, they all show the same therapeutic benefit. Even the small statistical difference between antidepressants and placebos may be an enhanced placebo effect, due to the fact that most patients and doctors in clinical trials successfully break blind. The serotonin theory is as close to any theory in the history of science having been proved wrong. Instead of curing depression, popular antidepressants may induce a biological vulnerability making people more likely to become depressed in the future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25304538     DOI: 10.1007/978-3-662-44519-8_16

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  10 in total

1.  Classical conditioning of antidepressant placebo effects in mice.

Authors:  Samuel R Krimmel; Panos Zanos; Polymnia Georgiou; Luana Colloca; Todd D Gould
Journal:  Psychopharmacology (Berl)       Date:  2019-08-17       Impact factor: 4.530

2.  Neuroinflammatory priming to stress is differentially regulated in male and female rats.

Authors:  Laura K Fonken; Matthew G Frank; Andrew D Gaudet; Heather M D'Angelo; Rachel A Daut; Emma C Hampson; Monica T Ayala; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2018-03-07       Impact factor: 7.217

Review 3.  Placebo eff ects in psychiatry: mediators and moderators.

Authors:  Katja Weimer; Luana Colloca; Paul Enck
Journal:  Lancet Psychiatry       Date:  2015-03       Impact factor: 27.083

Review 4.  Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicine.

Authors:  Katja Weimer; Luana Colloca; Paul Enck
Journal:  Gerontology       Date:  2015       Impact factor: 5.140

5.  Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies.

Authors:  Mark E Whitlock; Philip W Woodward; Robert C Alexander
Journal:  Innov Clin Neurosci       Date:  2019-07-01

Review 6.  Natural environments, ancestral diets, and microbial ecology: is there a modern "paleo-deficit disorder"? Part II.

Authors:  Alan C Logan; Martin A Katzman; Vicent Balanzá-Martínez
Journal:  J Physiol Anthropol       Date:  2015-03-10       Impact factor: 2.867

Review 7.  Dysbiotic drift: mental health, environmental grey space, and microbiota.

Authors:  Alan C Logan
Journal:  J Physiol Anthropol       Date:  2015-05-07       Impact factor: 2.867

8.  Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care.

Authors:  Rhona Eveleigh; Esther Muskens; Peter Lucassen; Peter Verhaak; Jan Spijker; Chris van Weel; Richard Oude Voshaar; Anne Speckens
Journal:  BJGP Open       Date:  2017-11-15

9.  Impact of spiritual healing on moderate depression in adults: a study protocol of a pilot randomised controlled trial (RCT).

Authors:  Trine Stub; Audun Campell Irgens; Anne Helen Hansen; Olav Knudsen-Baas; Cornelia Gåskjenn; Agnete E Kristoffersen
Journal:  BMJ Open       Date:  2022-09-15       Impact factor: 3.006

Review 10.  Putting the 'Art' Into the 'Art of Medicine': The Under-Explored Role of Artifacts in Placebo Studies.

Authors:  Michael H Bernstein; Cosima Locher; Tobias Kube; Sarah Buergler; Sif Stewart-Ferrer; Charlotte Blease
Journal:  Front Psychol       Date:  2020-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.